Waters (NYSE:WAT) Hits New 12-Month High – Time to Buy?
by Jessica Moore · The Cerbat GemWaters Co. (NYSE:WAT – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $411.75 and last traded at $409.71, with a volume of 51670 shares trading hands. The stock had previously closed at $404.00.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. Evercore ISI upped their price objective on shares of Waters from $335.00 to $355.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their price target on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday, November 4th. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a research note on Friday, January 10th. Bank of America increased their price target on shares of Waters from $400.00 to $430.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Finally, Barclays boosted their price objective on shares of Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Waters presently has a consensus rating of “Hold” and a consensus target price of $384.71.
View Our Latest Stock Report on WAT
Waters Price Performance
The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a 50-day moving average price of $378.88 and a 200 day moving average price of $351.45. The stock has a market capitalization of $24.57 billion, a price-to-earnings ratio of 39.58, a PEG ratio of 7.07 and a beta of 1.01.
Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.84 EPS. As a group, equities research analysts expect that Waters Co. will post 11.79 earnings per share for the current year.
Institutional Trading of Waters
A number of institutional investors have recently made changes to their positions in WAT. Fenimore Asset Management Inc raised its position in shares of Waters by 0.3% in the fourth quarter. Fenimore Asset Management Inc now owns 233,477 shares of the medical instruments supplier’s stock valued at $86,615,000 after buying an additional 713 shares during the last quarter. Fifth Third Bancorp raised its holdings in Waters by 3.9% in the 4th quarter. Fifth Third Bancorp now owns 2,221 shares of the medical instruments supplier’s stock valued at $824,000 after acquiring an additional 84 shares during the last quarter. Brighton Jones LLC lifted its stake in Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Waters by 39.2% during the 4th quarter. Janney Montgomery Scott LLC now owns 4,624 shares of the medical instruments supplier’s stock worth $1,715,000 after purchasing an additional 1,301 shares during the last quarter. Finally, Advisory Alpha LLC grew its position in shares of Waters by 2.6% in the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier’s stock valued at $395,000 after purchasing an additional 27 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Stories
- Five stocks we like better than Waters
- Investing in Construction Stocks
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Find and Profitably Trade Stocks at 52-Week Lows
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?